Viewing Study NCT00211133

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:53 AM
Ignite Modification Date: 2026-01-22 @ 10:46 AM
Study NCT ID: NCT00211133
Status: COMPLETED
Last Update Posted: 2010-11-30
First Post: 2005-09-13
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study to Evaluate the Impact of Maintaining Hemoglobin Levels Using Epoetin Alfa in Patients With Metastatic Breast Cancer Receiving Chemotherapy
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Anemia View
None Breast Neoplasms View
None Quality of Life View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Anemia View
None Breast Cancer View
None Breast Tumor View
None Quality of Life View
None Women View
None Female View
None Chemotherapy View
None Hemoglobin View
None Survival View
None Epoetin View
None Epoetin alfa View
None erythropoietin View